An analysis of the contact phase of blood coagulation: Effects of shear rate and surface are intertwined
- 1 March 1994
- journal article
- research article
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 22 (2) , 184-193
- https://doi.org/10.1007/bf02390376
Abstract
This work analyzes, for the first time, the combined role of blood flow, protein transport and the reaction network of the contact phase up to the “common pathway” of the blood coagulation cascade. The model is comprised of a set of 20 dominant reactions with 11 components. Systems of ODEs reducible to 4 coupled equations describe rigorously the dynamic behavior, while systems of algebraic equations, reducible to a single polynomial equation, model the steady state concentrations of the coagulants. The analysis showed that there is never more than onestable steady state. This is in contrast to the analysis of common pathway that gives rise to multiple concentration states. It also revealed a general robustness of the system to changes in procoagulant concentrations, inhibition rates and most activation rate constants. The system is largely impervious to the level of activated Factor XII, given that a trace (non-zero) level is present. In contrast, the system displays a dual response to flow and surface activity: A change in either of these factors alone can promote, have no effect on, or (in the case of flow) impede the progress of coagulation, depending on the value of the other factor. Their effects must therefore be examined in unison. These results may help resolve contradictory findings attributed to one or the other factor alone.Keywords
This publication has 24 references indexed in Scilit:
- Inhibition of factor XIa by antithrombin IIIBiochemistry, 1987
- The contact activation system: Biochemistry and interactions of these surface-mediated defense reactionsCritical Reviews in Oncology/Hematology, 1986
- Possible basis for the apparent surface selectivity of the contact activation of human blood coagulation factor XIIBiochemistry, 1986
- Surface-dependent activation of human factor XII (Hageman factor) by Kallikrein and its light chainEuropean Journal of Biochemistry, 1985
- Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.Journal of Clinical Investigation, 1984
- Interaction of human plasma kallikrein and its light chain with C.hivin.1 inhibitorBiochemistry, 1983
- Inactivation of Factor XIa by Plasma Protease InhibitorsJournal of Clinical Investigation, 1982
- Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in PlasmaJournal of Clinical Investigation, 1982
- THE KAOLIN CLOTTING TIMEJournal of Clinical Pathology, 1958
- THE CLOTTING BEHAVIOR OF HUMAN “PLATELET-FREE” PLASMA: EVIDENCE FOR THE EXISTENCE OF A “PLASMA THROMBOPLASTIN”Journal of Clinical Investigation, 1949